Geode Capital Management, LLC Bellus Health Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.14 - $8.53 $22,383 - $26,741	3,135 Added 2.77%	116,395 $838,000
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $296,665 - $397,764	33,147 Added 41.38%	113,260 $1.2 Million
Q2 2022 Aug 12, 2022	BUY	$6.46 - $10.02 $150,485 - $233,415	23,295 Added 41.0%	80,113 $738,000
Q3 2021 Nov 12, 2021	BUY	$2.7 - $6.64 $50,733 - $124,765	18,790 Added 49.41%	56,818 $348,000
Q1 2021 May 12, 2021	BUY	$3.03 - $4.58 $115,224 - $174,168	38,028 New	38,028 $146,000
Q4 2020 Feb 12, 2021	SELL	$2.27 - $3.3 $78,442 - $114,034	-34,556 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.88 - $11.15 $120,137 - $150,848	13,529 Added 64.34%	34,556 $357,000
Q1 2020 May 14, 2020	BUY	$5.77 - $10.85 $121,325 - $228,142	21,027 New	21,027 $209,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.